Daiichi Sankyo
Kaley Lugo, PharmD, MBA, RPh, serves as the Associate Director of Medical Review in Medical Information & Education at Daiichi Sankyo, Inc., since May 2019, where previous roles included Lead Manager and Manager in the same department focusing on Oncology. Kaley has been an Editorial Board Member for the DIA Global Forum since January 2019 and completed a post-doctoral fellowship in Medical Affairs, Neurology at Acorda Therapeutics, Inc. from July 2017 to May 2019 while also serving as an Adjunct Professor of Pharmacy at Rutgers University. Early career experiences include roles as a Ballet Barre Instructor and Pharmacy Intern at CVS Pharmacy. Academic achievements include a Doctorate in Pharmacy and an MBA from the University of Rhode Island.
This person is not in any teams
This person is not in any offices
Daiichi Sankyo
21 followers
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries. The Ranbaxy Group segment includes its core company, Ranbaxy Laboratories Ltd. Both group segments deal with business activities in prescription drugs and general pharmaceutical products. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.